InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-11.3%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Kalali Amir H, Director. Insider active across 1 company, notably ATAI Life Sciences N.V.. Aggregated, 2 disclosures have been published. Split: 2 buys · 0 sell. Total volume traded: €117k. History available since 22 June 2021. The latest transaction was filed on 22 June 2021 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
4,666 shares@ US$15.0050.0% of flowCommon SharesSEC:0000899243-21-025740
Ideal exit: 19 Mar 2022 (T+270)
4,666 shares@ US$15.000.0039% mcap50.0% of flowCommon SharesSEC:0000899243-21-025740:0
Ideal exit: 19 Mar 2022 (T+270)
2 of 2 declarations
About Kalali Amir H
Amir H. Kalali is a Board Member at ATAI Life Sciences N.V. He plays a crucial role in the governance of the company, providing strategic advice and overseeing research and development initiatives. His expertise is essential for innovation in the life sciences sector.
